| |
Crude prevalence
|
Age and sex adjusted OR (95%-CI)
|
|---|
| |
Dutch (n = 440)
|
Moroccan (n = 272)
|
Turkish (n = 320)
|
Moroccan versus Dutch
|
Turkish versus Dutch
|
|
IB
|
|
-High
|
38 (8.6)
|
103 (37.9)
|
138 (41.1)a
|
7.0 (4.6–10.8)b
|
10.8 (7.0–16.5)b
|
|
-Intermediate
|
110 (25.0)
|
155 (57.0)
|
165 (51.6)
| | |
|
-Low
|
292 (66.4)
|
14 (5.1)
|
17 (5.3)
| | |
|
HSV1 positive
|
281 (63.9)
|
269 (98.9)
|
308 (96.3)a
|
60.5 (18.9–193.3)
|
19.0 (10.2–35.5)
|
|
HSV2 positive
|
100 (22.7)
|
43 (15.8)
|
35 (10.9)a
|
0.68 (0.45–1.0)
|
0.45 (0.30–0.69)
|
|
HAV positive
|
217 (49.3)
|
261 (96.0)
|
310 (96.9)a
|
35.6 (18.4–69.2)
|
22.2 (27.6–110.5)
|
|
HBV positive
|
25 (5.7)
|
77 (28.3)
|
120 (37.5)a
|
6.8 (4.1–11.2)
|
13.6 (8.3–22.2)
|
|
HCV positive
|
1 (0.2)
|
1 (0.4)
|
0 (0)
|
–
|
–
|
|
H.pylori positive
|
252 (57.3)
|
267 (98.2)
|
313 (97.8)a
|
46.5 (18.6–116.0)
|
44.6 (20.2–98.2)
|
- Data are given as n (%) or as median (minimum-maximum), IB infectious burden measured by the number of infections (HSV1, HSV2, HAV, HBV, HCV and H.pylori) a participant was seropositive for. With the term infection we in this study refer to antibody seropositivity, a measure reflecting current or past infection. The subcategories are: low (0–2 infections), intermediate (3 infections) and high (4–6 infections); HSV1 herpes simplex virus 1, HSV2 herpes simplex virus 2, HAV hepatitis virus A, HBV hepatitis virus B, HCV hepatitis virus C, H.pylori Helicobacter pylori, OR odds ratio, CI confidence interval, a p-value univariate comparison < 0.001, b Comparison made between high IB and other
